Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Comment on: Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
Singh, Manraj , Bakhshi, Sameer , Ganguly, Shuvadeep , Sra, Manraj Singh

Pediatric Blood & Cancer | September 4, 2024 | Volume: 72 | Issue: 1 | Pages: No page available

10.1002/pbc.31305 | PMID 39228042 Get It

Children and Adolescents With Sickle Cell Disease and Skull Infarction: A Systematic Review
Vivar, Alexia Peréz , García-Guáqueta, Danna P. , Setty, Bindu N. , Neri, Caitlin M. , Torres, Alcy , Perez, Alexia M , Torres, Alcy R

Journal of Child Neurology | September 4, 2024 | Volume: 39 | Issue: 11-12 | Pages: 433-439

10.1177/08830738241274352 | PMID 39228213 Get It

Introduction Skull infarction is an uncommonly reported complication of sickle cell disease. We aimed to characterize the clinical and imaging features of skull infarction in pediatric patients with sickle cell disease. Methods We searched the PubMed database for case reports on skull bone infarction in pediatric patients with sickle cell disease. Out of 67 records retrieved, 15 met inclusion criteria, and a 16th case reported by the senior author was included. We extracted and analyzed clinical and imaging data. Results The most common symptom at onset was headache (88%). Bilateral skull infarction (50%) and parietal bone involvement (82%) were frequent imaging findings. Epidural hematoma developed in 65% of the cases, 30% of patients required drainage, and exchange infusion was reported in 18%. No fatal outcomes were reported. Conclusions Skull infarction is a potentially severe complication of sickle cell disease presenting unique clinical challenges. Acute headaches should raise suspicion for this condition and may require additional investigation.
Evaluation of Interprofessional Delivery of Diabetes Medication Management Training Among Family Medicine Residents
Davis, K.A. , Moore, Elise , Samuelson, Britanee, Stonerock, Lauren R. , Miller, Nathaniel E. , Davis, Amanda, Davis, Katherine , Stonerock, Lauren, Miller, Nathaniel E , Davis, Amanda

Journal of Primary Care & Community Health | September 4, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241276801 | PMID 39228176 Get It

Objective: Diabetes-related care makes up approximately 24% of outpatient clinic visits. Therefore, confidence and understanding of diabetes management is necessary for family medicine residents. Methods: We developed a combined lecture and simulation lab curriculum utilizing a registered nurse and pharmacist to deliver education to 20 family medicine learners. Pre and post surveys of the educational material were completed in 2 sections including one gauging medical knowledge and a second part gauging level of comfort. Results: Of the learners who participated, fourteen completed the pre-post surveys. Most (53%) respondents improved their scores, while 20% scored the same 27% scored worse. The overall average score increased 57% to 70% and improvement was statistically significant ( P < .05). All learners improved confidence by at least 1 point. Conclusion: An interprofessional team utilizing a lecture curriculum focusing on providing education on effective prescribing, medication safety profiles, and resource availability, showed improvement in confidence but mixed knowledge benefit. Further modifications to the curriculum may yield further educational gains.
Current state of the pain medicine match: perspective and an eye to the future
Aggarwal, Anuj , Barad, Meredith , Chai, Nu Cindy , Furnish, Timothy , Mishra, Puneet , Kohan, Lynn , Moeschler, Susan M. , Reddy, Rajiv , Yalamuru, Bhavana , Aggarwal, Anuj Kailash , Moeschler, Susan, Reddy, Rajiv , Barad, Meredith J

Regional Anesthesia & Pain Medicine | September 4, 2024 | Volume: 50 | Issue: 12 | Pages: 982-984

10.1136/rapm-2024-105770 | PMID 39231574 Get It

The National Resident Matching Program (NRMP) for pain medicine fellowships marked its 10th anniversary in 2023, coinciding with growing discussions within the Association of Pain Program Directors (APPD) regarding the program’s future in the context of a recent decline of applicants into pain medicine. This letter explores the rationale behind reassessing the NRMP’s utility for pain medicine, examining historical and current trends, and considering the implications of withdrawing from the match. Despite a recent decline in applicants and an increase in unfilled positions, the APPD advocates for continued participation in the match. The match ensures equitable and stable recruitment, preventing the chaotic pre-match environment of competitive, early offers. Data from similar specialties highlight the pitfalls of non-match systems, such as increased applicant pressure and reduced program visibility. The APPD supports maintaining the NRMP match while implementing reforms like preference signaling to address evolving challenges. The APPD aims to preserve the match’s benefits and ensure a stable future for pain medicine fellowship recruitment.
Patient’s plight to self-advocacy: the battle is won, the war goes on
D’Souza, Ryan S. , D'Souza, Ryan S

Regional Anesthesia & Pain Medicine | September 4, 2024 | Volume: 51 | Issue: 1 | Pages: 109-110

10.1136/rapm-2024-105924 | PMID 39231575 Get It

Response by Kosiborod et al to Letter Regarding Article, “Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial”
Kosiborod, Mikhail , Petrie, Mark C. , Borlaug, Barry A. , Kosiborod, Mikhail N , Borlaug, Barry A , Petrie, Mark C

Circulation | September 3, 2024 | Volume: 150 | Issue: 10 | Pages: No page available

10.1161/circulationaha.124.069707 | PMID 39226383 Get It

Clinical Utility of Serum C-Peptide Concentration for Hospitalized Patients with Hyperglycemia
Costa, Damla N. , Kudva, Yogish C. , Karakaplan, Nesrin Damla , Jensen, Michael D., Shah, Pankaj R.

Diabetes Technology & Therapeutics | September 3, 2024 | Volume: 27 | Issue: 2 | Pages: 121-127

10.1089/dia.2024.0246 | PMID 39226586 Get It

Background: Serum C-peptide concentration is often utilized for diagnostic, prognostic, or therapeutic assessment in diabetes mellitus. However, there are limited clinical data regarding diagnostic and predictive value of C-peptide measured during hospitalizations for hyperglycemia. Materials and Methods: Adults admitted to Mayo Clinic inpatient facilities due to an acute hyperglycemic emergency between January 2017 and November 2022 were included in our study. Predictive capacity of C-peptide for discontinuation of therapeutic insulin was examined in the entire cohort and the subgroup of non-autoimmune non-pancreatitis diabetes (NANP-DM). Results: We included 187 patients (63 women) in our study. During hospitalization, patients with type 1 diabetes antibodies displayed diminished serum C-peptide concentration ( P = 0.014), correlating inversely with subsequent hemoglobin A1c% [ r = (−0.22), P = 0.005]. Initial C-peptide concentrations did not differ between patients requiring insulin therapy during follow-up and those who did not ( P = 0.16). C-peptide concentrations showed limited predictive capacity for achieving glycemic control. Subgroup analyses in NANP-DM exhibited similar limited capacity for anticipating therapeutic insulin needs and achieving glycemic controls. Discussion: C-peptide concentration did not exhibit a robust predictive capability for future need of insulin therapy and achieving glycemic control, limiting its utility in clinical practice within inpatient settings.
Multiparametric MRI Scoring System of the Pancreas for the Diagnosis of Chronic Pancreatitis
Tirkes, Temel , Yadav, Dhiraj , Conwell, Darwin L. , Zhao, Xuandong, Dasyam, Anil K. , Halappa, Vivek Gowdra, Patel, Aashish, Shah, Zarine K. , Swensson, Jordan , Takahashi, Naoki , Wachsman, Ashley, Yang, Yunlong, Hart, Phil A. , Park, Walter G. , Vege, Santhi Swaroop , Topazian, Mark , Territo, Paul R. , Persohn, Scott A., Andersen, Dana K. , Fogel, Evan L. , Venkatesh, Sudhakar K , Takahashi, Naoki , Dasyam, Anil K , Venkatesh, Sudhakar K. , Li, Liang , Jennings, Kristofer , Pandol, Stephen J.

Journal of Magnetic Resonance Imaging | September 3, 2024 | Volume: 61 | Issue: 5 | Pages: 2183-2194

10.1002/jmri.29594 | PMID 39225586 Get It

BackgroundDuctal features alone may not offer high diagnostic sensitivity or most accurate disease severity of chronic pancreatitis (CP).PurposeDiagnose CP based on multiparametric MRI and MRCP features.Study TypeProspective.PopulationBetween February 2019 and May 2021, 46 control (23 males, 49.3 ± 14.1 years), 45 suspected (20 males, 48.7 ± 12.5 years), and 46 definite (20 males, 53.7 ± 14.6 years) CP patients were enrolled at seven hospitals enrolled in the MINIMAP study. CP classification was based on imaging findings and clinical presentation.Field Strength and Sequences1.5 T. T1‐weighted (T1W) spoiled gradient echo, T1 map with variable flip angle, dual‐echo Dixon, secretin‐enhanced MRCP before and after secretin infusion.AssessmentDual‐echo fat fraction (FF), T1 relaxation time, extracellular volume (ECV), T1 signal intensity ratio of the pancreas to the spleen (T1 score), arterial‐to‐venous enhancement ratio (AVR), pancreatic tail diameter (PTD), pancreas volume, late gadolinium enhancement, pancreatic ductal elasticity (PDE), and duodenal filling grade of secretin‐enhanced MRCP were measured.Statistical TestsLogistic regression analysis generated CP‐MRI and secretin‐enhanced CP‐SMRI scores. Receiver operating characteristics analysis was used to differentiate definite CP from control. Interobserver agreement was assessed using Lin's concordance correlation coefficient.ResultsCompared to control, definite CP cohort showed significantly higher dual‐echo FF (7% vs. 11%), lower AVR (1.35 vs. 0.85), smaller PTD (2.5 cm vs. 1.95 cm), higher ECV (28% vs. 38%), and higher incidence of PDE loss (6.5% vs. 50%). With the cut‐off of >2.5 CP‐MRI score (dual‐echo FF, AVR, and PTD) and CP‐SMRI score (dual‐echo FF, AVR, PTD, and PDE) had cross‐validated area under the curves of 0.84 (sensitivity 87%, specificity 68%) and 0.86 (sensitivity 89%, specificity 67%), respectively. Interobserver agreement for both CP‐MRI and CP‐SMRI scores was 0.74.ConclusionThe CP‐MRI and CP‐SMRI scores yielded acceptable performance and interobserver agreement for the diagnosis of CP.Evidence Level1Technical EfficacyStage 2
Procurement Trends, Indications, and Outcomes of Heart–Lung Transplantation in the Contemporary Era
Treffalls, John A. , Brennan, Zachary , Chen, Qiudong , Pennington, Kelly M. , Spencer, Philip J. , Villavicencio, Mauricio A. , Daly, Richard C. , Saddoughi, Sahar A. , Griffeth, Elaine M. , Chen, Qiudong , Pennington, Kelly , Spencer, Philip J , Bilgili, Ahmet , Sharaf, Omar M.

Clinical Transplantation | September 3, 2024 | Volume: 38 | Issue: 9 | Pages: No page available

10.1111/ctr.15447 | PMID 39225590 Get It

ABSTRACTBackgroundEvolving trends in organ procurement and technological innovation prompted an investigation into recent trends, indications, and outcomes following combined heart–lung transplantation (HLTx).MethodsThe United Network for Organ Sharing database was queried for all adult (≥18 years) HLTx performed between July 1, 2013 and June 30, 2023. Patients with previous transplants were excluded. The primary endpoint was the effect of donor, recipient, and transplantation characteristics on 1‐ and 5‐year survival. Secondary analyses included a comparison of HLTx at high‐ and low‐volume centers, an assessment of HLTx following donation after circulatory death (DCD), and an evaluation of HLTx volume over time. Cox proportional‐hazards models were used to assess factors associated with mortality. Temporal trends were evaluated with linear regression.ResultsAfter exclusions, 319 patients were analyzed, of whom 5 (1.6%) were DCD. HLTx volume increased from 2013 to 2023 (p < 0.001). One‐ and 5‐year survival following HLTx was 84.0% and 59.5%, respectively. One‐year survival was higher for patients undergoing HLTx at a high‐volume center (88.3% vs. 77.9%; p = 0.012). After risk adjustment, extracorporeal membrane oxygenation support 72 h posttransplant and predischarge dialysis were associated with increased 1‐year mortality (HR = 3.19, 95% CI = 1.86–5.49 and HR = 3.47, 95% CI = 2.17–5.54, respectively) and 5‐year mortality (HR = 2.901, 95% CI = 1.679–5.011 and HR = 3.327, 95% CI = 2.085–5.311, respectively), but HLTx at a high‐volume center was not associated with either.ConclusionsHLTx volume has resurged, with DCD HLTx emerging as a viable procurement strategy. Factors associated with 1‐ and 5‐year survival may be used to guide postoperative management following HLTx.